Bone mineral density and fracture prevalence in long-term kidney graft recipients
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 74 (4) , 496-500
- https://doi.org/10.1097/00007890-200208270-00011
Abstract
Background. Renal transplantation triggers an early bone loss that increases the subsequent risk of osteoporosis and fractures. Little is known about the long-term outcome of bone status and fracture prevalence several years after transplantation. Therefore, we conducted a cross-sectional evaluation of bone status to find out the frequency and predictors of osteoporotic fractures in late kidney graft patients. Methods. Changes in spinal, hip, and total body bone mineral density were assessed using a DEXA Hologic QRD 1000 scanner, and fractures were quantified in all kidney graft patients presenting for routine evaluation with a minimal follow-up of 5 years after transplantation (with a mean follow-up 8.5±3.1 years). We measured biochemical markers of bone metabolism and collected clinical and dietary intake data. Results. Fifty-nine renal graft recipients were enrolled in the study within 9 months. Osteoporosis, according to the World Health Organization definition, was observed in 31 patients (53% of the total population) and fractures occurred in 26 patients (44% of the total population and 51.6% of patients with osteoporosis). Femoral neck bone mineral density was positively correlated with patient’s weight and cyclosporin current dosage. Steroid cumulative dosage correlated only to lumbar spine Z score. Dietary calcium, serum 25 hydroxyvitamin D, parathyroid hormone, and urinary N-telopeptides excretion were normal. Conclusions. These data emphasize the substantial prevalence of osteoporosis and fractures among very long-term kidney graft recipients. Therapeutic intervention in these patients is urgently needed.Keywords
This publication has 13 references indexed in Scilit:
- Osteoporosis after Organ TransplantationThe American Journal of Medicine, 1998
- EFFECTS OF THREE IMMUNOSUPPRESSIVE REGIMENS ON VERTEBRAL BONE DENSITY IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1997
- Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal studyAmerican Journal of Kidney Diseases, 1996
- Post-transplantation bone disease: The role of immunosuppressive agents and the skeletonJournal of Bone and Mineral Research, 1996
- BONE MINERAL DENSITY AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVOTransplantation, 1994
- Changes in bone mass early after kidney transplantationJournal of Bone and Mineral Research, 1994
- Rapid Loss of Vertebral Mineral Density after Renal TransplantationNew England Journal of Medicine, 1991
- Cyclosporin-Ain VitroDecreases Bone Resorption, Osteoclast Formation, and the Fusion of Cells of the Monocyte-Macrophage LineageEndocrinology, 1991
- Cyclosporin a induces in vivo inhibition of resorption and stimulation of formation in rat boneJournal of Bone and Mineral Research, 1989